Virtu Financial LLC Invests $607,000 in CME Group Inc (CME) Stock

Share on StockTwits

Virtu Financial LLC bought a new position in CME Group Inc (NASDAQ:CME) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,563 shares of the financial services provider’s stock, valued at approximately $607,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CME. Cornerstone Wealth Management LLC bought a new position in CME Group in the 2nd quarter worth about $153,000. Dupont Capital Management Corp lifted its stake in CME Group by 30.5% during the 2nd quarter. Dupont Capital Management Corp now owns 3,326 shares of the financial services provider’s stock valued at $545,000 after acquiring an additional 777 shares during the period. First Trust Advisors LP lifted its stake in CME Group by 140.9% during the 2nd quarter. First Trust Advisors LP now owns 278,048 shares of the financial services provider’s stock valued at $45,578,000 after acquiring an additional 162,604 shares during the period. Jennison Associates LLC bought a new position in CME Group during the 2nd quarter valued at about $1,058,000. Finally, Alps Advisors Inc. bought a new position in CME Group during the 2nd quarter valued at about $1,640,000. Hedge funds and other institutional investors own 85.89% of the company’s stock.

Several research firms have issued reports on CME. Zacks Investment Research upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research note on Tuesday, September 18th. Citigroup began coverage on shares of CME Group in a research note on Tuesday, November 20th. They set a “buy” rating and a $220.00 target price on the stock. Atlantic Securities began coverage on shares of CME Group in a research note on Wednesday, November 28th. They set a “neutral” rating and a $200.00 target price on the stock. Bank of America restated a “buy” rating and set a $200.00 target price on shares of CME Group in a research note on Monday, November 5th. Finally, Deutsche Bank upped their target price on shares of CME Group from $205.00 to $206.00 and gave the company a “buy” rating in a research note on Friday, November 16th. Six research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. CME Group has a consensus rating of “Buy” and a consensus price target of $194.13.

In related news, Director Martin J. Gepsman sold 300 shares of the stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $172.30, for a total value of $51,690.00. Following the completion of the sale, the director now directly owns 42,912 shares of the company’s stock, valued at approximately $7,393,737.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Chairman Terrence A. Duffy sold 10,000 shares of the stock in a transaction that occurred on Friday, November 23rd. The stock was sold at an average price of $188.80, for a total transaction of $1,888,000.00. Following the completion of the sale, the chairman now directly owns 95,652 shares of the company’s stock, valued at $18,059,097.60. The disclosure for this sale can be found here. Insiders have sold a total of 29,800 shares of company stock valued at $5,628,462 in the last ninety days. Insiders own 0.43% of the company’s stock.

NASDAQ CME opened at $187.11 on Friday. CME Group Inc has a 52 week low of $143.68 and a 52 week high of $197.08. The stock has a market cap of $64.24 billion, a PE ratio of 39.23, a price-to-earnings-growth ratio of 2.19 and a beta of 0.46. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.15.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, October 25th. The financial services provider reported $1.45 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.42 by $0.03. CME Group had a net margin of 113.67% and a return on equity of 9.18%. The firm had revenue of $904.20 million during the quarter, compared to analyst estimates of $910.50 million. Sell-side analysts forecast that CME Group Inc will post 6.66 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 27th. Stockholders of record on Monday, December 10th will be given a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a dividend yield of 1.50%. The ex-dividend date is Friday, December 7th. CME Group’s payout ratio is currently 58.70%.

COPYRIGHT VIOLATION NOTICE: This article was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another publication, it was stolen and reposted in violation of US and international copyright law. The original version of this article can be viewed at https://www.tickerreport.com/banking-finance/4001269/virtu-financial-llc-invests-607000-in-cme-group-inc-cme-stock.html.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Read More: Hedge Funds Explained

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Supernus Pharmaceuticals Inc  Shares Bought by Allianz Asset Management GmbH
Supernus Pharmaceuticals Inc Shares Bought by Allianz Asset Management GmbH
Artisan Partners Asset Management Inc  Holdings Lessened by Allianz Asset Management GmbH
Artisan Partners Asset Management Inc Holdings Lessened by Allianz Asset Management GmbH
Alliancebernstein L.P. Has $5.66 Million Stake in Cars.com Inc.
Alliancebernstein L.P. Has $5.66 Million Stake in Cars.com Inc.
Oclaro Inc  Holdings Raised by Alliancebernstein L.P.
Oclaro Inc Holdings Raised by Alliancebernstein L.P.
Adelante Capital Management LLC Has $1.46 Million Holdings in CoreSite Realty Corp
Adelante Capital Management LLC Has $1.46 Million Holdings in CoreSite Realty Corp
Alliancebernstein L.P. Has $6.12 Million Position in Builders FirstSource, Inc.
Alliancebernstein L.P. Has $6.12 Million Position in Builders FirstSource, Inc.


Leave a Reply

© 2006-2018 Ticker Report